The AF4·MLL fusion protein is capable of inducing ALL in mice without requirement of MLL·AF4

Blood

Volumn 115, Issue 17, 2010, Pages 3570-3579

  Bursen, Adelheid ^a   Schwabe, Karen ^a   Rüster, Brigitte ^b   Henschler, Reinhard ^b   Ruthardt, Martin ^a   Dingermann, Theo ^a   Marschalek, Rolf ^a  

^a GOETHE UNIVERSITY   (Germany)

^b German Red Cross Blood Service   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AF4 MIXED LINEAGE LEUKEMIA FUSION PROTEIN; MIXED LINEAGE LEUKEMIA AF4 FUSION PROTEIN; ONCOPROTEIN; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; MLL PROTEIN, MOUSE; MLLT2H PROTEIN, MOUSE; NUCLEAR PROTEIN;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; FUSION GENE; GENETIC TRANSDUCTION; IMMUNOPHENOTYPING; LEUKEMIA; LEUKEMOGENESIS; MIXED LINEAGE LEUKEMIA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CELL TRANSFORMATION; CHROMOSOME; GENE EXPRESSION REGULATION; GENE TRANSLOCATION; GENETICS; HUMAN; MALE; METABOLISM;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, MAMMALIAN; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; MALE; MICE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TRANSDUCTION, GENETIC; TRANSLOCATION, GENETIC;

EID: 77951749557     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-06-229542     Document Type: Article

References (39)

1. Nilson I, Löchner K, Siegler G, et al. Exon/intron structure of the human ALL-1 (MLL) gene involved in translocations to chromosomal region 11q23 and acute leukaemias. Br J Haematol. 1996;93(4):966-972. (Pubitemid 26199341)
2. Rasio D, Schichman SA, Negrini M, Canaani E, Croce CM. Complete exon structure of the ALL1 gene. Cancer Res. 1996;56(8):1766-1769. (Pubitemid 26118211)
3. Cleary ML. Oncogenic conversion of transcription factors by chromosomal translocations. Cell. 1991;66(4):619-622. (Pubitemid 121001698)
4. Rabbitts TH. Translocations, master genes, and differences between the origins of acute and chronic leukemias. Cell. 1991;67(4):641-644.
5. Rabbitts TH. Chromosomal translocations in human cancer. Nature. 1994;372:143-149.
6. Meyer C, Kowarz E, Hofmann J, et al. New insights into the MLL recombinome of acute leukemias. Leukemia. 2009;23(8):1490-1499.
7. Kowarz E, Burmeister T, Lo Nigro L, et al. Complex MLL rearrangements in t(4;11) leukemia patients with absent AF4·MLL fusion allele. Leukemia. 2007;21(6):1232-1328.
8. Corral J, Lavenir I, Impey H, et al.An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Cell. 1996;85(6):853-861. (Pubitemid 26192136)
9. Lavau C, Szilvassy SJ, Slany R, Cleary ML. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J. 1997;16(14):4226-4237. (Pubitemid 27298175)
10. Slany RK, Lavau C, Cleary ML. The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNAbinding motifs of HRX. Mol Cell Biol. 1998;18(1):122-129. (Pubitemid 28021024)
11. DiMartino JF, Miller T, Ayton PM, et al. A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL. Blood. 2000;96(12):3887-3893.
12. Lavau C, Luo RT, Du C, Thirman MJ. Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice. Proc Natl Acad Sci U SA. 2000;97(20):10984-10989.
13. So CW, Karsunky H, Passegué E, Cozzio A, Weissman IL, Cleary ML. MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice. Cancer Cell. 2003;3(2):161-171. (Pubitemid 37443388)
14. Ono R, Ihara M, Nakajima H, et al. Disruption of Sept6, a fusion partner gene of MLL, does not affect ontogeny, leukemogenesis induced by MLL-SEPT6, or phenotype induced by the loss of Sept4. Mol Cell Biol. 2005;25(24):10965-10978. (Pubitemid 41747139)
15. Strehl S, Borkhardt A, Slany R, Fuchs UE, König M, Haas OA. The human LASP1 gene is fused to MLL in an acute myeloid leukemia with t(11;17)(q23;q21). Oncogene. 2003;22(1):157-160. (Pubitemid 36152894)
16. Ayton PM, Cleary ML. Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev. 2003;17(18):2298-2307.
17. Zeisig BB, Milne T, Garcia-Cuellar MP, et al. Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization. Mol Cell Biol. 2004;24(2):617-628. (Pubitemid 38057914)
18. DiMartino JF, Ayton PM, Chen EH, Naftzger CC, Young BD, Cleary ML. The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10. Blood. 2002;99(10):3780-3785.
19. Martin ME, Milne TA, Bloyer S, et al. Dimerization of MLL fusion proteins immortalizes hematopoietic cells. Cancer Cell. 2003;4(3):197-207. (Pubitemid 37163834)
20. So CW, Lin M, Ayton PM, Chen EH, Cleary ML. Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias. Cancer Cell. 2003;4:99-110. (Pubitemid 37040826)
21. Eguchi M, Eguchi-Ishimae M, Greaves M. The small oligomerization domain of gephyrin converts MLL to an oncogene. Blood. 2004;103(10):3876-3882. (Pubitemid 38596308)
22. Chen W, Li Q, Hudson WA, Kumar A, Kirchhof N, Kersey JH. A murine MLL·AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy. Blood. 2006;108(2):669-677. (Pubitemid 44061369)
23. Metzler M, Forster A, Pannell R, et al. A conditional model of MLL·AF4 B-cell tumourigenesis using invertor technology. Oncogene. 2006;25(22):3093-3103. (Pubitemid 43881551)
24. Krivtsov AV, Feng Z, Lemieux ME, et al. H3K79 methylation profiles define murine and human MLL·AF4 leukemias. Cancer Cell. 2008;14(5):355-368.
25. Caslini C, Serna A, Rossi V, Introna M, Biondi A. Modulation of cell cycle by graded expression of MLL·AF4 fusion oncoprotein. Leukemia. 2004;18(6):1064-1071. (Pubitemid 38786964)
26. Gaussmann A,Wenger T, Eberle I, et al. Combined effects of the two reciprocal t(4;11) fusion proteins MLL·AF4 and AF4·MLL confer resistance to apoptosis, cell cycling capacity and growth transformation. Oncogene. 2007;26(23):3352-3363. (Pubitemid 46788884)
27. Bursen A, Moritz S, Gaussmann A, Dingermann T, Marschalek R. Interaction of AF4 wild-type and AF4·MLL fusion protein with SIAH proteins: indication for t(4;11) pathobiology? Oncogene. 2004;23(37):6237-6249. (Pubitemid 39215294)
28. Grignani F, Kinsella T, Mencarelli A, et al. High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res. 1998;58(1):14-19. (Pubitemid 28027708)
29. Greil J, Gramatzki M, Burger R, et al. The acute lymphoblastic leukaemia cell line SEM with t(4;11) chromosomal rearrangement is biphenotypic and responsive to interleukin-7. Br J Haematol. 1994;86(2):275-283. (Pubitemid 24198988)
30. Marschalek R, Greil J, Löchner K, et al. Molecular analysis of the chromosomal breakpoint and fusion transcripts in the acute lymphoblastic SEM cell line with chromosomal translocation t(4;11). Brit J Haematol. 1995;90(2):308-320.
31. Morse HC III, Anver MR, Fredrickson TN, et al. Bethesda proposals for classification of lymphoid neoplasms in mice. Blood. 2002;100(1):246-258. (Pubitemid 35177454)
32. National Center for Biotechnology Information. Gene Expression Omnibus (GEO). http://www.ncbi.nlm.nih.gov/geo.
33. Trentin L, Giordan M, Dingerman T, et al. Two independent gene signatures in pediatric t(4;11) acute lymphoblastic leukemia patients. Eur J Haematol. 2009;83(5):406-419.
34. Stam RW, Schneider P, Hagelstein JA, et al. Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants. Blood. 2010;115(14):2835-2844.
35. Nakamura T, Mori T, Tada S, et al. ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol Cell. 2002;10(5):1119-1128. (Pubitemid 35453829)
36. Dou Y, Milne TA, Tackett AJ, et al. Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyl-transferase MOF. Cell. 2005;121(6):873-885. (Pubitemid 40806419)
37. Milne TA, Dou Y, Martin ME, BrockHW, Roeder RG, Hess JL. MLL associates specifically with a subset of transcriptionally active target genes. Proc Natl Acad Sci U S A. 2005;102(41):14765-14770. (Pubitemid 41457130)
38. Wysocka J, Swigut T, Milne TA, et al. WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development. Cell. 2005;121(6): 859-872. (Pubitemid 40806418)
39. Bitoun E, Oliver PL, Davies KE. The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling. Hum Mol Genet. 2007;16(1):92-106. (Pubitemid 46152547)